"At Acuity Pharmaceuticals we faced many challenges back in 2003. Five years later, we can view our scientific and financial successes with the benefit of hindsight to seek the contributing factors to that success. BioAdvance was one of the first companies we presented our company to. We received quick feedback and then were involved in a thorough diligence process which gave us more input and encouragement. At that early juncture, BioAdvance decided to invest, yet it was far more than money that made the difference. The BioAdvance team provided contacts and an effective sounding board for our development during those formative years."
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
BioAdvance and Portfolio News Coverage
| 2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 |
2008
|
June 5, 2008 - The Philadelphia Inquirer
Malvern's Protez being purchased by Novartis |
| > View Article |
|
June 5, 2008 - The Wall Street Journal
Novartis Will Purchase Biotech Company Protez |
| > View Article |
|
June 4, 2008 - BioWorld Today
Deal for Protez Gives Novartis Superbug Candidate |
| > View Article |
|
June 4, 2008 - The Boston Globe Online
Novartis buys drug firm Protez for up to $400 mln |
| > View Article |
|
June 4, 2008 - FierceBiotech
Novartis eyes vaccines with Protez purchase |
| > View Article |
|
June 4, 2008 - The Philadelphia Business Journal
Protez Pharmaceuticals to be bought by Novartis |
| > View Article |
|
June 4, 2008 - Reuters
Novartis buys Protez for up to $400M |
| > View Article |
|
June 4, 2008 - Associated Press / Money Central / MSN
Novartis buys antibiotics maker Protez |
| > View Article |
|
June 4, 2008 - Thompson Merger News
Novartis to Acquire Protez for up to $400M |
| > View Article |
|
June 4, 2008 - Forbes.com
Novartis Ups Fight Vs. Drug-Resistant Infections |
| > View Article |
|
June 1, 2008 - Genetic Engineering and Biotechnology News
Tips for Emerging Firms on Obtaining Funding |
| > View Article |
|
May 13, 2008 - The Reporter
Specter Deserves Thanks |
|
May 12, 2008 - BioCentury
Protez Pharmaceuticals Inc. and Dainippon Sumitomo Pharma Co. Ltd. -- PZ-601 |
|
May 10, 2008 - The Philadelphia Inquirer
Protez to begin testing its injectable antibiotic |
|
May 9, 2008 - Pennsylvania BIO Watch
Protez Initiates Phase II Study for Its Lead Product PZ-601 in Infectious Diseases |
| > View Article |
|
May 8, 2008 - Philadelphia Business Journal
Protez takes aim at infection problem plaguing patients |
|
May 1, 2008 - PharmaVoice
Seeding Early-Stage Research |
| > View Article |
|
April 7, 2008 - NJ Biz
VC Firms Bet Big on Biotech Startups, But Want Lesser Risk |
| > View Article |
|
March 6, 2008 - Fierce Biotech
Finding Sources to Fund a Biotech Startup |
| > View Article |
|
March 1, 2008 - Drug Discovery & Development
Headache Relief (NuPathe) |
|
February 22, 2008 - Drug Week, Clinical Oncology Week
John Gill an Steven Nichtberger, M.D. Join BioAdvance Board of Directors |
|
February 18, 2008 - The Philadelphia Inquirer
On the Boards: BioAdvance... Appointed John M. Gill and Steven Nichtberger, M.D. |
|
February 3, 2008 - Venture Wire Life Sciences
BioAdvance Adds Two CEOs to Board |
|
January 28, 2008 - Pain and CNS Week, Pharma Business Week
World-class Speaking Faculty Leads Discussion on Changing the Direction of Prevention and Treatment at the 10th Annual Alzheimer's Disease Conference (Avid) |
|
January 21, 2008 - Drug Week, Health and Medicine Week
NuPathe Names George Moonsammy, PhD as Vice President of Development |
|
January 21, 2008 - The Philadelphia Inquirer
Fourth Quarter Venture Capital Investments (Yaupon Therapeutics) |
|
January 1, 2008 - Genetic Engineering News
Repositioning Idle Drugs Via Systematic Serendipity (Melior Discovery) |
|
January 1, 2008 - The Scientist
Barbara Schilberg: A Champion for the Region |
| > View Article |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.